SGLT2 inhibitor use reduces progression and surgical intervention of persistent pulmonary nodules
{{output}}
Objective: In-situ and early-stage cancers are the fastest growing subset of pulmonary malignancies, often presenting as persistent nodules and ground glass opacities. These lesions are frequently surveilled, though many progress... ...
